Skip to main content

Table 1 Demographic and stimulation data of included patients

From: Sequential E2 levels not ovarian maximal diameter estimates were correlated with outcome of cetrotide therapy for management of women at high-risk of ovarian hyperstimulation syndrome: a randomized controlled study

Data

Control

Study

P value

Age (years)

Strata

≤25

6 (25%)

11 (45.8%)

>0.05

26–30

11 (45.8%)

8 (33.3%)

>30

7 (29.2%)

5 (20.9%)

Total

28.6 ± 3.3

27 ± 4

>0.05

BMI data

Weight (kg)

78 ± 6.1

80.5 ± 7.7

>0.05

Height (cm)

168 ± 3.6

167 ± 4.2

>0.05

BMI (kg/m2)

Strata

<25

6 (25%)

3 (12.5%)

>0.05

25–30

14 (58.3%)

12 (50%)

>30

4 (16.7%)

9 (37.5%)

Total

27.6 ± 2.4

28.9 ± 2.9

>0.05

Duration of infertility

Strata

≤5

7 (29.2%)

8 (33.3%)

>0.05

>5

17 (70.8%)

16 (66.7%)

Total

3.8 ± 2

4.2 ± 2.1

Cause of infertility

Male factor

11 (45.8%)

10 (41.6%)

>0.05

Female factor

5 (20.9%)

7 (29.2%)

Mixed

8 (33.3%)

7 (29.2%)

PCOS

Yes

20 (83.3%)

19 (79.1%)

>0.05

No

4 (16.7%)

5 (20.9%)

Basal FSH (mIU/ml)

7.5 ± 1

7.31 ± 0.77

>0.05

Total gonadotrophin dose (IU/ml)

1605 ± 404

1475.4 ± 382

>0.05

Time of stimulation (days)

8.1 ± 1.4

8.2 ± 1.6

>0.05

HCG dose (IU/ml)

5800 ± 1500

5977 ± 1788

>0.05

  1. Data are presented as mean ± SD & numbers; percentages are in parenthesis